Julia is an associate editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2022. She produces written and video content covering multiple disease states, and assists in the screening process for manuscripts submitted to AJMC®.
She has a BA in English language and literature from Rutgers University. You can connect with Julia on LinkedIn.
What We’re Reading: Listeria Outbreak; COVID-19 Death Decline; Eli Lilly Pays in Drug Patent Trial
November 10th 2022A listeria outbreak has been linked to deli meats and cheeses; the World Health Organization announced that there has been a 90% drop in recent deaths in COVID-19 globally compared with 9 months ago; Eli Lilly was ordered to pay $176.5 million in a US migraine drug patent trial.
Read More
Guideline-Directed Medical Therapies Focus on Adherence, Cost in Patients With HFrEF
November 7th 2022Posters presented at the American Heart Association's Scientific Sessions elaborated on the results of out-of-pocket expenses and adherence for guideline-directed medical therapies in patients with heart failure with reduced ejection fraction (HFrEF).
Read More
The VICTORIA Trial: What It Means for HFrEF Treatment
November 7th 2022Posters presented at the American Heart Association conference in Chicago, Illinois, evaluated the insights from the VICTORIA trial and their generalizability to patients hospitalized with heart failure with reduced ejection fraction (HFrEF).
Read More
KCCQ-12 Improved Accuracy of Health Status Assessment in Heart Failure Clinic
November 5th 2022Research presented at the American Heart Association (AHA) Scientific Sessions in Chicago, Illinois, found that the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) was able to assess patients’ symptoms more accurately for clinicians.
Read More
Data Presented at AHA Shows Medicare's HRRP Only Cut Readmissions for the Wealthy
November 5th 2022Posters presented at the American Heart Association (AHA) Scientific Sessions in Chicago, Illinois, found that the neighborhood income and socioeconomic status had an effect on heart failure and all-cause readmission rates.
Read More
Glomerular Filtration Rate Based on Cystatin C More Accurate for Predicting CVD, Mortality
November 3rd 2022A prospective population-based cohort study found that glomerular filtration rate based on cystatin C was more sensitive and specific for cardiovascular disease (CVD) and mortality risks compared with glomerular filtration rate based on creatinine.
Read More
Diabetic Kidney Disease Progression Associated With Changes in Muscle, Fat Amounts
November 1st 2022Patients with type 2 diabetes with a high to very high prognostic risk of diabetic kidney disease were more likely to have a reduced rectus femoris cross-sectional area, a measure of muscle mass in the lower body, and an increased visceral fat area.
Read More
Dr Michel Michaelides Speaks About Implications of Gene Therapy Study Results in Ophthalmology
October 27th 2022The results of a study showing improved functional vision and retinal sensitivity have implications for gene therapy in ophthalmological conditions, explained Michel Michaelides, MD, FACP, a consultant ophthalmologist and a professor of ophthalmology at the University College London Institute of Ophthalmology's Genetics Department.
Read More
2 Commerce Drive
Cranbury, NJ 08512